Beiersdorf reports USD 10.8B sales in FY25 amid challenging market

GERMANY – Beiersdorf has reported full-year 2025 results showcasing strategic resilience with €9.9 billion (USD 10.8 billion) in group sales amid a slowing skin care market.

Group sales reached €9,852 million (USD 10.7 billion), marking 2.4% organic growth despite nominal flatness from €9,850 million (USD 10.7 billion) in 2024, while EBIT excluding special factors climbed to €1,378 million (USD 1.50 billion) for a 14.0% margin. 

Consumer Business delivered €8,176 million (USD 8.9 billion) in sales with 2.5% organic growth, and Tesa contributed €1,676 million (USD 1.83 billion) with 1.8% growth. 

Profit after tax rose to €955 million (USD 1.04 billion) while the gross cash flow hit €1,075 million (USD 1.17 billion) alongside €463 million (USD 505 million) capex and €365 million (USD 398 million) R&D spend.

Vincent Warnery, CEO of Beiersdorf, stated, “2025 was a demanding year for the skin care industry, marked by slowing growth and continued market volatility.”

“Our Derma business continued its strong momentum, driven by breakthrough innovations and targeted expansion into white spaces.”

Skin care drove 3.7% organic growth, making Beiersdorf the top global performer, led by Derma’s 11.7% surge to €1,492 million (USD 1.63 billion), driven by hits like Epigenetics Serum and Thiamidol®. 

NIVEA grew 0.9% organically to €5,529 million (USD 6.03 billion) despite challenges, boosted by late innovations; Health Care jumped 9.3% to €299 million (USD 326 million); La Prairie fell 4.5% to €478 million (USD 521 million)but stabilized. 

Regions saw 0.9% growth in Europe, 3.1% in the Americas, and 4.5% in Africa/Asia/Australia.

A late-2025 recalibration balanced NIVEA investments across Face Care, Body Care, and Deodorants, prioritizing local tailoring in key markets like China, the US, India, Japan, and Brazil. 

This evolution sustains Face Care focus while building agility, with sustained innovation and marketing through 2026-2027.

Tesa posted 1.8% organic growth to €1,676 million (USD 1.83 billion) amid automotive headwinds, excelling in Electronics and Printing/Packaging, with an EBIT margin of 16.1% excluding special factors. 

Organic group net sales are forecast to be flat to modestly higher, with Consumer EBIT margin slightly below 2025 levels due to raw materials and FX; Tesa aligns similarly. 

In Q1 2026, the company anticipates softer performance due to US retail issues, China travel retail, and fading NIVEA launches.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.